• Slideshow_knowmorehepc

  • slide_obamacare_greaterthan

  • slide_prepvideos

  • Slideshow_hivhealthreform

  • Slideshow_prep

Much more is needed beyond CA Governor’s proposed investment in hepatitis C and HIV

post_proposal

FOR IMMEDIATE RELEASE:    January 22, 2015 Contact:  Anne Donnelly, adonnelly@projectinform.org, (415) 640-6103; Emalie Huriaux, ehuriaux@projectinform.org,  (415) 580-7301   Project Inform Acknowledges Governor Brown’s Proposed Investment in Hepatitis C and HIV, But Much More is Needed to Address These Epidemics and Promote Public Health SAN FRANCISCO, CA –…Read More

I have hepatitis C. What are my treatment options?

post_hcv

As the options for treating hepatitis C (HCV) are increasing, so is the confusion. This is a good problem to have: with more treatment options come more opportunities for people with various HCV genotypes (GT), treatment history and varying levels of cirrhosis to get cured. But…Read More

HIV/HCV co-infection news from the 2014 AASLD Liver Meeting

post_aasld

Approximately 10,000 doctors, researchers, and advocates from around the world gathered in Boston in November for the 65th Meeting of the American Association for the Study of Liver Diseases (AASLD), also known as “The Liver Meeting.” Over 400 abstracts at the conference focused on hepatitis C…Read More

The New Hep C Drug Competition: Will patients win, or just for-profit companies?

post_drugcosts

On October 10 and December 19, 2014, the U.S. Food and Drug Administration (FDA) approved two new all-oral, interferon-free medications for treating hepatitis C in patients with genotype 1: Gilead’s Harvoni and Abbvie’s Viekira Pak, respectively. The presence on the market of two medications with comparable…Read More

Project Inform helps lead effort to “Get to Zero” in San Francisco

post_zero

San Francisco leads US cities in its progress against HIV. Higher percentages of HIV-positive people know their status, are linked to care and treatment and are virally suppressed than in the rest of the nation. Additionally, newly diagnosed cases of HIV infection have declined significantly in…Read More

Project Inform to mark 30 years of leadership and impact

post_30years_sm

April of 2015 marks the 30th year of the founding of Project Inform by Martin Delaney and Joe Brewer. Since its creation, the agency has earned global respect for its leadership in stimulating research into the development of safe and effective treatments for HIV; representing the…Read More

Hepatitis C drug Victrelis (boceprevir) gets pulled from manufacturer

post_victrelis

The pharmaceutical company, Merck, has announced that they will stop the manufacture and distribution of their hepatitis C (HCV) protease inhibitor Victrelis by December 2015. As the landscape of HCV treatment has rapidly evolved, providers are no longer prescribing the medication and patients are no longer…Read More